• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】32036

【品名】2,4-difluoro-1-nitrobenzene

【CA登记号】446-35-5

【 分 子 式 】C6H3F2NO2

【 分 子 量 】159.0921664

【元素组成】C 45.3% H 1.9% F 23.88% N 8.8% O 20.11%

与该中间体有关的原料药合成路线共 11 条

合成路线1

该中间体在本合成路线中的序号:(I)

The condensation of 2,5-difluoronitrobenzene (I) with ethyl 2-amino-5-methylthiophene-3-carboxylate (II) by means of triethylamine in hot DMSO or 2-methoxyethanol giving ethyl 2-(4-fluoro-2-nitroanilino)-5-methylthiophene-3-carboxylate (III), which is reduced with H2 over Pd/C in ethanol to ethyl 2-(4-fluoro-2-aminoanilino)-5-methylthiophene-3-carboxylate (IV). The cyclization of (IV) by means of NaH in DMSO affords 9,10-dihydro-7-fluoro-2-methyl-4H-thieno[2,3b][1,5]benzodiazepin-2-one (V), which is finally condensed with N-methylpiperazine by means of TiCl4 in anisole at 120 C.

1 Chakrabarti, J.K.; Tupper, D.E.; Benzodiazepine derivatives. DE 2552403; FR 2292479; GB 1533235; JP 51076296 .
2 Pullar, I.A.; Chakrabarti, J.K.; Horsman, L.; Wright, F.C.; Tupper, D.E.; Hotten, T.M.; Heterooarenobenzodiazepines. 3. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics. J Med Chem 1980, 23, 8, 878-884.
3 Blancafort, P.; Castañer, J.; Serradell, M.N.; Flumezapine. Drugs Fut 1983, 8, 2, 110.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 35949 ethyl 2-amino-5-methyl-3-thiophenecarboxylate C8H11NO2S 详情 详情
(III) 35950 ethyl 2-(5-fluoro-2-nitroanilino)-5-methyl-3-thiophenecarboxylate C14H13FN2O4S 详情 详情
(IV) 35951 ethyl 2-(2-amino-5-fluoroanilino)-5-methyl-3-thiophenecarboxylate C14H15FN2O2S 详情 详情
(V) 35952 7-fluoro-2-methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepin-4-one C12H9FN2OS 详情 详情
(VI) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The title compound has been obtained by two related ways: Condensation of glycine ethyl ester (II) with 2,4-difluoronirobenzene (I) provided the N-arylglycine (III), which was further reduced to the phenylenediamine derivative (IV) by catalytic hydrogenation. Acylation of diamine (IV) with ethyl chloroglyoxylate, followed by ring closure in refluxing ethanol, yielded the quinoxalinedione (V). Subsequent electrophyllic nitration of (V) furnished the 6-nitroquinoxaline (VI). The fluoride group of (III) was then displaced with imidazole (VII) in hot DMF yielding the imidazolyl quinoxaline (VIII). Finally, basic hydrolysis of the ethyl ester function of (VIII) gave the target carboxylic acid.

1 Shishikura, J.; Inami, H.; Sakamoto, S.; Tsukamoto, S.; Sasamata, M.; Okada, M.; Fujii, M. (Yamanouchi Pharmaceutical Co., Ltd.); 1,2,3,4-Tetrahydroquinoxalindione deriv.. EP 0784054; US 6096743; WO 9610023 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 10309 ethyl 2-aminoacetate; Glycine ethyl ester 459-73-4 C4H9NO2 详情 详情
(III) 58528 ethyl 2-(5-fluoro-2-nitroanilino)acetate C10H11FN2O4 详情 详情
(IV) 58529 ethyl 2-(2-amino-5-fluoroanilino)acetate C10H13FN2O2 详情 详情
(V) 58530 ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate C12H11FN2O4 详情 详情
(VI) 58531 ethyl 2-[7-fluoro-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate C12H10FN3O6 详情 详情
(VII) 10255 Imidazole; 1H-Imidazole 288-32-4 C3H4N2 详情 详情
(VIII) 58532 ethyl 2-[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate C15H13N5O6 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

The intermediate arylpiperazine (VI) was prepared as follows: Reaction of 2,4-difluoronitrobenzene (I) with trifluoroethanol (II) in the presence of potassium tert-butoxide yielded the trifluoroethyl ether (III). After catalytic hydrogenation of the nitro group of (III), the resultant aniline (IV) was cyclized with bis(2-chloroethyl) amine hydrochloride (V) in a refluxing mixture of o-dichlorobenzene and n-hexanol to afford the target piperazine (VI).

1 Bantle, G.W.; Elworthy, T.R.; Guzman, A.; Jaime-Figueroa, S.; Lopez-Tapia, F.J.; Morgans, D.J. Jr.; Perez-Medrano, A.; Pfister, J.R.; Sjogren, E.B.; Talamas, F.X. (F. Hoffmann-La Roche AG); Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivs. as alpha1-adrenergic receptor antagonists. EP 0748800; JP 1997100269 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 19483 2,2,2-trifluoro-1-ethanol 75-89-8 C2H3F3O 详情 详情
(III) 54365 4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene; 5-fluoro-2-nitrophenyl 2,2,2-trifluoroethyl ether C8H5F4NO3 详情 详情
(IV) 54366 4-fluoro-2-(2,2,2-trifluoroethoxy)aniline; 4-fluoro-2-(2,2,2-trifluoroethoxy)phenylamine C8H7F4NO 详情 详情
(V) 21583 2-chloro-N-(2-chloroethyl)-1-ethanamine; Bis(2-chloroethyl)amine; 1,1'-iminobis(2-chloroethane); N,N-bis(2-chloroethyl)amine 821-48-7 C4H9Cl2N 详情 详情
(VI) 54367 1-[4-fluoro-2-(2,2,2-trifluoroethoxy)phenyl]piperazine; 5-fluoro-2-(1-piperazinyl)phenyl 2,2,2-trifluoroethyl ether C12H14F4N2O 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Treatment of 2,4-difluoronitrobenzene (I) with isopropylamine in the presence of K2CO3 in THF afforded 2-isopropylamino-4-fluoronitrobenzene (II). Subsequent condensation of (II) with 2,3-difluorophenylacetonitrile (III) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (IV) with H2O2 generated benzophenone (V). The nitro group of (V) was then reduced by hydrogenation over Raney Nickel yielding diamine (VI), which was cyclized to benzimidazole (VII) upon treatment with cyanogen bromide. Addition of the lithium anion of N-methyl-N-(trimethylsilyl)acetamide to (VII) gave beta-hydroxyamide (VIII). Finally, acid promoted dehydration of (VIII) furnished the corresponding alpha,beta-unsaturated amide.

1 Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 37887 5-fluoro-N-isopropyl-2-nitroaniline; N-(5-fluoro-2-nitrophenyl)-N-isopropylamine C9H11FN2O2 详情 详情
(III) 37888 2-(2,3-difluorophenyl)acetonitrile 145689-34-5 C8H5F2N 详情 详情
(IV) 37889 2-(2,3-difluorophenyl)-2-[3-(isopropylamino)-4-nitrophenyl]acetonitrile C17H15F2N3O2 详情 详情
(V) 37890 (2,3-difluorophenyl)[3-(isopropylamino)-4-nitrophenyl]methanone C16H14F2N2O3 详情 详情
(VI) 37891 [4-amino-3-(isopropylamino)phenyl](2,3-difluorophenyl)methanone C16H16F2N2O 详情 详情
(VII) 37892 (2-amino-1-isopropyl-1H-benzimidazol-6-yl)(2,3-difluorophenyl)methanone C17H15F2N3O 详情 详情
(VIII) 37894 3-(2-amino-1-isopropyl-1H-benzimidazol-6-yl)-3-(2,3-difluorophenyl)-3-hydroxy-N-methylpropanamide C20H22F2N4O2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

Treatment of 2,4-difluoronitrobenzene (I) with isopropylamine in the presence of K2CO3 in THF afforded 2-isopropylamino-4-fluoronitrobenzene (II). Subsequent condensation of (II) with 2,3-difluorophenylacetonitrile (III) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (IV) with H2O2 generated benzophenone (V). The nitro group of (V) was then reduced by hydrogenation over Raney Nickel yielding diamine (VI), which was cyclized to benzimidazole (VII) upon treatment with cyanogen bromide. Addition of the lithium anion of bis(trimethylsilyl)acetamide to (VII) gave beta-hydroxyamide (VIII). Finally, acid promoted dehydration of (VIII) furnished the corresponding alpha,beta-unsaturated amide, which was isoalted as the hydrochloride salt.

1 Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 37887 5-fluoro-N-isopropyl-2-nitroaniline; N-(5-fluoro-2-nitrophenyl)-N-isopropylamine C9H11FN2O2 详情 详情
(III) 37888 2-(2,3-difluorophenyl)acetonitrile 145689-34-5 C8H5F2N 详情 详情
(IV) 37889 2-(2,3-difluorophenyl)-2-[3-(isopropylamino)-4-nitrophenyl]acetonitrile C17H15F2N3O2 详情 详情
(V) 37890 (2,3-difluorophenyl)[3-(isopropylamino)-4-nitrophenyl]methanone C16H14F2N2O3 详情 详情
(VI) 37891 [4-amino-3-(isopropylamino)phenyl](2,3-difluorophenyl)methanone C16H16F2N2O 详情 详情
(VII) 37892 (2-amino-1-isopropyl-1H-benzimidazol-6-yl)(2,3-difluorophenyl)methanone C17H15F2N3O 详情 详情
(VIII) 37893 3-(2-amino-1-isopropyl-1H-benzimidazol-6-yl)-3-(2,3-difluorophenyl)-3-hydroxypropanamide C19H20F2N4O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

Treatment of 2,4-difluoronitrobenzene (I) with cyclopentylamine (II) in the presence of K2CO3 in THF afforded 2-cyclopentylamino-4-fluoronitrobenzene (III). Subsequent condensation of (III) with 2-fluorophenylacetonitrile (IV) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (V) with H2O2 generated benzophenone (VI). The nitro group of (VI) was then reduced by hydrogenation over Raney Nickel yielding diamine (VII), which was cyclized to benzimidazole (VIII) upon treatment with cyanogen bromide. Addition of the lithium anion of N-methyl-N-(trimethylsilyl)acetamide to (VIII) gave beta-hydroxyamide (IX). Finally, acid promoted dehydration of (IX) furnished the corresponding alpha,beta-unsaturated amide, whic was isolated as the hydrochloride salt.

1 Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 28850 cyclopentanamine 1003-03-8 C5H11N 详情 详情
(III) 37895 N-cyclopentyl-N-(5-fluoro-2-nitrophenyl)amine; N-cyclopentyl-5-fluoro-2-nitroaniline C11H13FN2O2 详情 详情
(IV) 37888 2-(2,3-difluorophenyl)acetonitrile 145689-34-5 C8H5F2N 详情 详情
(V) 37896 2-[3-(cyclopentylamino)-4-nitrophenyl]-2-(2-fluorophenyl)acetonitrile C19H18FN3O2 详情 详情
(VI) 37897 [3-(cyclopentylamino)-4-nitrophenyl](2-fluorophenyl)methanone C18H17FN2O3 详情 详情
(VII) 37898 [4-amino-3-(cyclopentylamino)phenyl](2-fluorophenyl)methanone C18H19FN2O 详情 详情
(VIII) 37899 (2-amino-1-cyclopentyl-1H-benzimidazol-6-yl)(2-fluorophenyl)methanone C19H18FN3O 详情 详情
(IX) 37900 3-(2-amino-1-cyclopentyl-1H-benzimidazol-6-yl)-3-(2-fluorophenyl)-3-hydroxy-N-methylpropanamide C22H25FN4O2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

The condensation of 2,4-difluoronitrobenzene (I) with 2(S)-aminobutyric acid (II) by means of triethylamine in refluxing acetone gives 2(S)-(5-fluoro-2-nitrophenylamino)butyric acid (III), which is reductocyclized with H2 over Raney-Ni in methanol/acetic acid, yielding 3(S)-ethyl-6-fluoro-1,2,3,4-tetrahydroquinoxalin-2-one (IV). Finally, this compound is treated with isopropyl chloroformate (V) and 4-methylpyridine in dichloromethane.

1 Rosner, M.; Billhardt-Troughton, U.-M.; Kirsch, R.; Kleim, J.-P.; Meichsner, C.; Riess, G.; Winkler, I. (Aventis SA); Quinoxalines, process for their preparation, and their use. CA 2160859; DE 4437406; EP 0708093; JP 1996225544; US 5723461 .
2 Graul, A.; Castañer, J.; Rabasseda, X.; GW-420867X. Drugs Fut 2000, 25, 1, 24.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(II) 32037 (2S)-2-aminobutyric acid 1492-24-6 C4H9NO2 详情 详情
(III) 32038 (2S)-2-(5-fluoro-2-nitroanilino)butyric acid C10H11FN2O4 详情 详情
(IV) 32039 (3S)-3-ethyl-6-fluoro-3,4-dihydro-2(1H)-quinoxalinone C10H11FN2O 详情 详情
(V) 26492 2-[(chlorocarbonyl)oxy]propane 108-23-6 C4H7ClO2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The condensation of ethyl 2-aminobenzo[b]thiophene-3-carboxylate (I) with 2,4-difluoronitrobenzene (II) afforded the diaryl amine (III). The nitro group of (III) was then reduced to amine (IV) by catalytic hydrogenation over Pd/C. Then, cyclization of amino ester (IV) with N-methylpiperazine (V) using TiCl4 in hot anisole produced the target benzothienobenzodiazepine, which was finally isolated as the corresponding maleate salt.

1 Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46396 ethyl 2-amino-1-benzothiophene-3-carboxylate C11H11NO2S 详情 详情
(II) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(III) 46397 ethyl 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate C17H13FN2O4S 详情 详情
(IV) 46398 ethyl 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carboxylate C17H15FN2O2S 详情 详情
(V) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

In a related procedure, the condensation of 2-aminobenzo[b]thiophene-3-carbonitrile (VI) with 2,4-difluoronitrobenzene (II) produced the diaryl amine (VII). Reduction of the nitro group of (VII) using sodium hydrosulfite yielded diamine (VIII). Subsequent cyclization of amino nitrile (VIII) upon acidic treatment gave rise to the tetracyclic system (IX). This was then treated with refluxing N-methylpiperazine (V) to provide the title compound.

2 Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
1 Horiuchi, H.; Kimura, K.; Tanaka, H.; et al.; Y-931, a novel antipsychotic with potential anti-NRH (NMDA receptor-hypofunction) activity: Synthesis and structure-activity relationships of 6H-[1]benzothieno[2,3-b][1,5]benzodiazepines. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-128.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(V) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情
(VI) 46399 2-amino-1-benzothiophene-3-carbonitrile C9H6N2S 详情 详情
(VII) 46400 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile C15H8FN3O2S 详情 详情
(VIII) 46401 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carbonitrile C15H10FN3S 详情 详情
(IX) 46402 8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-ylamine; 8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-amine C15H10FN3S 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

 

1 Harada K, Nishino S, Hirotsu K, et aL. 2002. Process for producing 5-fluorooxyindole and for producing intermediate therefor. W0 2002006228
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(III) 66755 methyl 5-fluoro-2-oxoindoline-3-carboxylate   C10H8FNO3 详情 详情
(IV) 60384 5-fluoro-1,3-dihydro-2H-indol-2-one 56341-41-4 C8H6FNO 详情 详情

合成路线11

该中间体在本合成路线中的序号:(I)

Reaction of 2,4-difluoronitrobenzene (I) with liquid ammonia gives 5-fluoro-2-nitroaniline (IIa) , which by subsequent displacement of the remaining fluoride group with N-methylpiperazine (III) in the presence of Et3N in NMP at 100 °C provides the piperazinyl aniline (IV) . Alternatively, nitroaniline (IV) can be prepared by condensation of 5-chloro-2-nitroaniline (IIb) with N-methylpiperazine (III) in hot EtOH , ethylene glycol or aqueous NaCl, optionally in the presence of NaOH . Catalytic hydrogenation of nitroaniline (IV) over Pd/C in EtOH at 40-45 °C yields the phenyldiamine (V) , wh ich by condensa t ion with ethyl 3-ethoxy-3-iminopropionate hydrochloride (VI) at reflux produces benzimidazole (VII) . Cyclocondensation of ethyl ester (VII) with 2-amino-6-fluorobenzonitrile (VIII) by means of LiHMDS , KHMDS or t-BuOK in THF or toluene furnishes dovitinib (IX ) , which is finally treated with racemic lactic acid in EtOH/H2O .

1 Machajewski, T., Shafer, C., McCrea, B. et al. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. EP 1317442, EP 1650203, EP 1849782, JP 2004509112, US 2002107392, US 6605617, WO 2002022598.
2 Harrison, S.D., Shafer, C.M., Pecchi, S. et al. (Novartis Vaccines and Diagnostics, Inc.). Benzimidazole quinolines and uses thereof. EP 1539754, JP 2006503919, JP 2011162563, US 200409235, US 2013018058, WO 2004018419.
3 Renhowe, P.A., Pecchi, S., Machajewski, T.D. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. JP 2005527587, US 2003028018, WO 2003087095.
4 Cai, S., Chou, J., Harwood, E., Machajewski, T.D., Ryckman, D., Shang, X., Zhu, S. (Novartis Vaccines and Diagnostics, Inc.). Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties. CN 102225926, EP 1699421, JP 2007522098, JP 2011042687, WO 2005046589.
5 Renhowe, P.A., Pecchi, S., Shafer, C.M. et al. Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A novel class of receptor tyrosine kinase inhibitors. J Med Chem 2009, 52(2): 278-92.
6 Calvin, G., Harwood, E., Ryckman, D., Zhu, S. (Novartis AG). Methods for synthesizing heterocyclic compounds. EP 1888556, EP 2465857, JP 2008540675, US 2011046376, US 8222413, WO 2006125130.
7 Okhamafe, A., Chou, J., Gullapalli, R., Harwood, E., Ryckman, D., Zhu, S.,Shang, X. (Novartis Corp.). Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts. CN 102070614, EP 1904480, EP 2266974, EP 2270000, JP 200854289, US 2011178097, US 2012208825, WO 2006127926.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IIa) 67969 5-fluoro-2-nitroaniline 2369-11-1 C6H5FN2O2 详情 详情
(IIb) 15709 5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline 1635-61-6 C6H5ClN2O2 详情 详情
(I) 32036 2,4-difluoro-1-nitrobenzene 446-35-5 C6H3F2NO2 详情 详情
(III) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情
(IV) 67970 5-(4-methylpiperazin-1-yl)-2-nitroaniline   C11H16N4O2 详情 详情
(V) 31430 2-amino-4-(4-methyl-1-piperazinyl)phenylamine; 4-(4-methyl-1-piperazinyl)-1,2-benzenediamine 54998-08-2 C11H18N4 详情 详情
(VI) 67971 ethyl 3-ethoxy-3-iminopropionate hydrochloride 2318-25-4 C7H13NO3.HCl 详情 详情
(VII) 67972 ethyl 2-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate   C16H22N4O2 详情 详情
(VIII) 13857 5-Amino-2-fluorobenzonitrile; 2-Amino-6-fluorobenzonitrile 77326-36-4 C7H5FN2 详情 详情
(IX) 67973 4-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 405169-16-6 C21H21FN6O 详情 详情
Extended Information